1-7 of 7
Lotta Hansson, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

T Cells from Chronic Lymphocytic Leukemia (CLL) Patients Display Dysregulated Expression of Immune Checkpoint Molecules and Activation Markers Mainly Restricted to CD4 + Cells and Correlated with Disease Activity

Marzia Palma, MDPhD, Giusy Gentilcore, MSc, Fariba Mozaffari, PhD, Kia Heimersson, Barbro Näsman-Glaser, Lotta Hansson, MD PhD, Anders Österborg, MDPhD, Håkan Mellstedt, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4132.
https://doi.org/10.1182/blood.V126.23.4132.4132
Published: 2015
Journal Articles

Outcome of Second Line Treatment in Patients with Chronic Lymphocytic Leukemia Did Not Improve 2002-2013: A Population-Based Study from a Well-Defined Geographic Region

Anna Asklid, MD, Agnes Mattsson, MD, Einar Björgvinsson, MD, Maria Winqvist, MD, Sandra Eketorp Sylvan, MD PhD, Frans Søltoft, MSc, Johanna Repits, PhD, Joris Diels, Anders Österborg, MD PhD, Lotta Hansson, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4166.
https://doi.org/10.1182/blood.V126.23.4166.4166
Published: 2015
Journal Articles

Real-World Results on Ibrutinib in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL): Data from 97 Swedish Patients Treated in a Compassionate Use Program

Lotta Hansson, MD PhD, Maria Winqvist, MD, Anna Asklid, MD, P-O Andersson, MDPhD, Karin Karlsson, MD, Claes Karlsson, MDPhD, Birgitta Lauri, MD, Jeanette Lundin, MD PhD, Mattias Mattsson, MD, Stefan Norin, MDPhD, Anna Sandstedt, MD, Anders Österborg, MDPhD
Journal: Blood
Blood (2015) 126 (23): 1745.
https://doi.org/10.1182/blood.V126.23.1745.1745
Published: 2015
Journal Articles

Comparison of Phase 3 Ibrutinib Results Versus Standard of Care in Sweden in Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)

Anders Österborg, MD PhD, Anna Asklid, MD, Joris Diels, Johanna Repits, PhD, Frans Söltoft, MSc, Lotta Hansson, MD PhD, Ulrich Jäger, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1751.
https://doi.org/10.1182/blood.V126.23.1751.1751
Published: 2015
Journal Articles

Vaccination with Dendritic Cells Loaded with Autologous Leukemic Cells in Combination with Low-Dose Lenalidomide Induced Immune Responses in Chronic Lymphocytic Leukemia (CLL) Patients

Lotta Hansson, MD PhD, Marzia Palma, MD PhD, Lars Adamson, Harriet Ryblom, Barbro Näsman-Glaser, Ingrid Eriksson, Kia Heimersson, Giusy Gentilcore, Håkan Mellstedt, MD PhD, Anders Österborg
Journal: Blood
Blood (2014) 124 (21): 4685.
https://doi.org/10.1182/blood.V124.21.4685.4685
Published: 2014
Journal Articles

Early and Transient Microchimerism Associated with Complete Remission after Adoptively Transferred Haploidentical NK Cells Against High Risk Myelodysplastic Syndrome and Refractory Acute Myeloid Leukemia

Andreas T Björklund, MDPhD, Mattias Carlsten, MD PhD, Marie Schaffer, PhD, Lisa Liu, MD, Sarah A. Cooley, MD MS, Jeffrey S. Miller, MD, Emma Watz, MD, Marzia Palma, MD PhD, Lotta Hansson, MD PhD, Björn E Wahlin, MD PhD, Lars Möllgård, MDPhD, Hans Hagglund, MD PhD, Pontus Blomberg, PhD, Per T. Ljungman, MD PhD, Eva Hellström-Lindberg, MD PhD, Hans-Gustaf Ljunggren, MD PhD, Karl-Johan Malmberg, MD, PhD
Journal: Blood
Blood (2014) 124 (21): 1120.
https://doi.org/10.1182/blood.V124.21.1120.1120
Published: 2014
Journal Articles

Expression of Human Telomerase Reverse Transcriptase (hTERT) Splice Variants In Chronic Lymphocytic Leukemia (CLL)

Marzia Palma, MD, PhD, Parviz Kokhaei, PhD, Lotta Hansson, MD, PhD, Mohammad Hojat-Farsangi, PhD, Aniruddha Raja Choudhury, PhD, Anders Osterborg, MD, PhD, Håkan Mellstedt, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2413.
https://doi.org/10.1182/blood.V116.21.2413.2413
Published: 2010